custom image

Vaccinology in the Age of Pandemics:
Strategies Against COVID-19 & Other Global Threats

June 15–16, 2020 | 11:00AM–3:30PM ET | 3:00–7:30PM UTC | 5:00–9:30PM CEST*
*Program is subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

As the world faces the greatest global pandemic of our lifetimes, the critical importance of vaccine development has come to the forefront of scientific and public audiences alike. Over the course of history, vaccination has enabled us to conquer devastating diseases from measles to smallpox, but new challenges arise when addressing an emerging pandemic in real time. This virtual meeting will assemble the world’s leading vaccinology and global health experts to present the latest advances in vaccine design and development. Finally, this virtual conference will discuss how to best apply these strategies in the context of the current pandemic.

The field of vaccinology has made great leaps in recent years, providing novel technologies and approaches that can be leveraged to our advantage against the novel coronavirus, COVID-19. Incredible advances in science and technology now make it technically possible to develop vaccines against many new targets. Meanwhile, innovative approaches to vaccine development are tackling challenges of emerging infections and implementation in low-income countries. These advances, among many others, will guide the way towards a safe and effective COVID-19 vaccine. Additionally, these new scientific advances will set the stage for success against this pandemic, as vaccinologists race against the ever-rising global death toll.

This virtual meeting program will cover many important facets of vaccine science, technology and strategy, including:

  • transformative new technologies, including structure-based design, adjuvants, nucleic acid vaccines (especially RNA), viral vectors, systems biology, and controlled human infections
  • scientific underpinnings of new vaccinology strategies, including advances in the fields of human immunology, genomics, synthetic biology, molecular structure of antigens and antigen-antibody complexes, germinal centers, and microbiome
  • multidisciplinary technologies and strategies, including efforts of Coalition for Epidemic Preparedness Innovations (CEPI), Bill & Melinda Gates Foundation and Wellcome Trust, which will change the way vaccines are developed

Program is intended for scientific researchers and clinical audiences.

Join us for this landmark virtual event, brought to you by Keystone Symposia.

Apply Here for Free On Demand Access

Registration is now closed for this event.  Please join us for an upcoming eSymposia.


Please check the Agenda tab in the left-hand menu for most up-to-date program details.

Program Details

Keynote Speaker

Anthony S. Fauci, MD

Anthony S. Fauci, MD

NIAID, National Institutes of Health

Transforming Vaccinology: Considerations for the Next Decade

Speaking at this eSymposia


Galit Alter

MIT and Harvard University


Yasmine Belkaid

NIAID, National Institutes of Health

Anthony S. Fauci, MD

Anthony S. Fauci

NIAID, National Institutes of Health


George Fu Gao

Chinese Academy of Sciences


Barney S. Graham

NIAID, National Institutes of Health


Richard Hatchett

Coalition for Epidemic Preparedness Innovations, CEPI


Neil P. King

University of Washington


Antonio Lanzavecchia

Institute for Research in Biomedicine


Ulrike Protzer

Technische Universität München


Bali Pulendran

Stanford University School of Medicine


Rino Rappuoli

GlaxoSmithKline Vaccines


Federica Sallusto

Università della Svizzera Italiana & ETH Zurich


Robert A. Seder

NIAID, National Institutes of Health


Robin Shattock

Imperial College London


Lynda M. Stuart

Bill & Melinda Gates Foundation


Christine Shaw


Gabriel D. Victora

Gabriel D. Victora

Rockefeller University


Hedda Wardemann

German Cancer Research Center


Catherine J. Wu

Dana-Farber Cancer Institute


Editors Attending This Meeting

custom image

Teodoro-Pulvirenti, PhD 

Executive Editor, Journal of Experimental Medicine (JEM)

custom image

Gaia Trincucci, PhD 

Scientific Editor, Journal of Experimental Medicine (JEM)

custom image

Céline Carret, PhD

Scientific Editor, EMBO Molecular Medicine

custom image

Zeljko Durdevic, PhD

Scientific Editor, EMBO Molecular Medicine

custom image

Denise Doolan, PhD

Specialty Chief Editor, Frontiers in Immunology

custom image

Alessandra Fornarelli, Dr. rer. nat.

Journal Manager, Frontiers in Immunology


custom image

custom image

custom image

custom image

custom image

custom image

Funding for this conference was made possible (in part) by 1R13AI150086-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

custom image

custom image

custom image

custom image

Media In-Kind Sponsors





The Scientist


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.

custom image